# SAPHIRE (NCT02912312)

> Hypofractionated vs. Conventional Regional Nodal Radiation Therapy for Patients With Invasive Breast Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT02912312
- Phase: PHASE2
- Status: ACTIVE_NOT_RECRUITING
- Sponsor: M.D. Anderson Cancer Center
- Conditions: Invasive Breast Carcinoma; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7
- Interventions: Hypofractionated Radiation Therapy; Laboratory Biomarker Analysis; Quality-of-Life Assessment; Questionnaire Administration; Radiation Therapy
- Enrollment: 805
- Primary outcome: Lymphedema rate as assessed by perometry

## Indexed commentary on SAPHIRE so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- YouTube: 7
- Podcasts: 7
- X threads: 7

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=saphire-nct02912312

## Free preview

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT02912312", "email": "<work email>"}; the inbox owner confirms by the emailed link.